Drug Approval | May 04, 2022
Gland launches Bortezomib in the US market
Bortezomib for injection is used to treat certain types of cancer such as multiple myeloma and mantle cell lymphoma
Bortezomib for injection is used to treat certain types of cancer such as multiple myeloma and mantle cell lymphoma
Clobetasol Propionate Foam, 0.05% has an estimated market size of US $ IO million for twelve months ending Dec 2021 according to IQVIA
The tablets are available in 100 mg strength in bottle count sizes of 60
Ivabradine Tablets, 5 mg and 7.5 mg have an estimated market size of US $ 102 million for twelve months ending December 2021 according to IQVIA
Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022
This product will be manufactured at Lupin’s Nagpur facility in India
The product will be manufactured at Lupin’s facility in Goa, India
Lidocaine and Prilocaine Cream USP, 2.5%/2.5% has an estimated market size of US $ 29 million for twelve months ending Dec. 2021 according to IQVIA
The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Pradaxa Capsules of Boehringer lngelheim
Merzee is a generic equivalent of Taytulla of Allergan Pharmaceuticals International
Subscribe To Our Newsletter & Stay Updated
